Alternatives to Pharmmies
Pharmmies is a pharmaceutical startup focused on improving pediatric medication delivery through innovative formulations. Here are the 52 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Healthcare companies to Pharmmies
N-Power MedicineNot ratedN-Power Medicine is a healthcare technology company transforming oncology drug development and community cancer patient care.
CytoReasonNot ratedDevelops a computational model of the human body for drug discovery and development.
Nucleai3.0 out of 5 (1)AI-powered spatial biology platform for precision medicine and drug development.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
OncohostNot ratedLeveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.
Galderma Group3.0 out of 5 (1)A global pure-play dermatology company focused on injectable aesthetics, dermatological skincare, and therapeutic medicine.
MediWoundNot ratedGlobal leader in enzymatic therapeutics for non-surgical tissue repair, replacing existing standards of care.
ElicitNot ratedAI-powered research assistant for scientific literature review and data extraction.
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
AlgorithmiqNot ratedQuantum software company enabling breakthroughs in chemistry, materials science, and life sciences.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Spark TherapeuticsNot ratedA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
KaliVir Immunotherapeutics, Inc.5.0 out of 5 (1)Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
Rocket PharmaceuticalsNot ratedA biotechnology company developing genetic therapies for rare disorders.
Janux TherapeuticsNot ratedA clinical-stage biopharmaceutical company developing novel immunotherapies.
Showing the next 20 closest matches. See the rest on the Pharmmies profile.
Sponsored rows are paid and labelled. Advertise on this page
